Cargando…
Hospital clinical pathways for children affected by juvenile idiopathic arthritis
BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common pediatric chronic rheumatic disease, which requires constant follow-up over the years, due to relapses during its progression. To maintain a good quality of life, it is important to limit admissions as far as possible. With the devel...
Autores principales: | Cavazzana, L., Fornili, M., Filocamo, G., Agostoni, C., Auxilia, F., Castaldi, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245695/ https://www.ncbi.nlm.nih.gov/pubmed/30458837 http://dx.doi.org/10.1186/s13052-018-0576-8 |
Ejemplares similares
-
Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
por: Baldo, Francesco, et al.
Publicado: (2021) -
Correction to: Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
por: Baldo, Francesco, et al.
Publicado: (2021) -
Does ultrasound agree with parent's perception of joint disease in juvenile idiopathic arthritis?
por: Biancardi, Carlo, et al.
Publicado: (2014) -
Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
por: Consolaro, A, et al.
Publicado: (2008) -
Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)